| Structure |
Chemical Name |
CAS |
MF |
 |
monocalcium mono((3R,5S,E)-7-(4-(3-fluorophenyl)-6-isopropyl-2- (N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6- enoate) |
|
|
 |
Canagliflozin Impurity 43 |
|
|
 |
4-(2-((2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzamide |
|
|
![9-[[(2E)-4-[[(2S,3R,4R,5S)-3α,4α-ジヒドロキシ-5β-[(2E,4S,5S)-5-ヒドロキシ-4-メチル-2-ヘキセニル]テトラヒドロ-2H-ピラン]-2β-イル]-3-メチル-2-ブテノイル]オキシ]ノナン酸](/CAS/20210111/GIF/71980-98-8.gif) |
9-[[(2E)-4-[[(2S,3R,4R,5S)-3α,4α-ジヒドロキシ-5β-[(2E,4S,5S)-5-ヒドロキシ-4-メチル-2-ヘキセニル]テトラヒドロ-2H-ピラン]-2β-イル]-3-メチル-2-ブテノイル]オキシ]ノナン酸 |
71980-98-8 |
C26H44O8 |
 |
Olopatadine Impurity 10 HBr |
4174-83-8 |
C22H26Br2NP |
 |
Empagliflozin Impurity 84 |
|
|
 |
Rivaroxaban Impurity 11 |
1411775-06-8 |
C14H17N3O4 |
 |
Conivaptan impurity |
1129433-63-1 |
C32H26N4O2 |
 |
(7R,8R)-Dihydrodehydrodiconiferyl alcohol 9-O-β-D-glucoside |
351346-10-6 |
C26H34O11 |
![4-(p-クロロベンジル)-2-[(ヘキサヒドロ-1H-アゼピン)-4-イル]フタラジン-1(2H)-オン](/CAS/GIF/47491-38-3.gif) |
4-(p-クロロベンジル)-2-[(ヘキサヒドロ-1H-アゼピン)-4-イル]フタラジン-1(2H)-オン |
47491-38-3 |
C21H22ClN3O |
 |
Amlodipine Impurity 9 |
90445-05-9 |
C26H31ClN2O8S |
 |
(S)-thiazolidine-4-carboxylic acid (D) |
|
C4H7NO2S |
 |
Tofacitinib Impurity 96 |
|
|
 |
トリフェニル(エトキシ)メタン |
968-39-8 |
C21H20O |
![Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]-](/CAS/20210305/GIF/769083-63-8.gif) |
Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]- |
769083-63-8 |
C19H24N2O |
 |
Androst-2-en-17-one, (5β)- |
82467-84-3 |
C19H28O |
 |
Olaparib Impurity 25 |
1423030-11-8 |
C16H9FO4 |
 |
Levofloxacin Impurity 7 |
1607796-83-7 |
C15H14FNO5 |
 |
(Z)-2-propylhept-2-enal |
95667-14-4 |
C10H18O |
 |
Olopatadine Impurity 11 HBr |
4174-84-9 |
C21H24Br2NP |
 |
Teneligliptin Impurity 12 |
|
|
 |
He pulls non-EP impurities D |
|
|
 |
Pterosin A-2-O-glucoside |
|
|
 |
5-メチル-2-(1H-1,2,3-トリアゾール-1-イル)安息香酸 |
1149352-55-5 |
C10H9N3O2 |
 |
Vortioxetine Impurity 2 |
1293489-69-6 |
C17H20N2S |
 |
Parecoxib Impurity D |
|
|
 |
3-pentylisoindolin-1-one |
691863-84-0 |
C13H17NO |
 |
(3S,5R,6E) Rosuvastatin Calcium Salt (2:1) |
2414245-11-5 |
C22H30CaFN3O6S |
 |
Lenvatinib Impurity 10 |
|
|
![TRANS-4-[[(2-AMINOPHENYL)METHYL]AMINO]-CYCLOHEXANOL](/CAS/20150408/GIF/46727-91-7.gif) |
TRANS-4-[[(2-AMINOPHENYL)METHYL]AMINO]-CYCLOHEXANOL |
46727-91-7 |
C13H20N2O |
 |
diphenhydramine impurity |
|
C17H21NO |
 |
Canagliflozin Impurity 21 |
|
|
 |
Solifenacin ring opening Impurity 11 |
|
|
 |
Doxylamine Impurity G |
|
|
 |
Sugammadex disulfide Impurity |
|
|
 |
Nirmatrelvir Impurity 5 |
3099985-26-6 |
|
 |
Olaparib Impurity 31 |
458535-34-7 |
C12H18N2O2 |
 |
3-(β-D-グルコピラノシルオキシ)-3',4',5,5',7-ペンタヒドロキシフラボン |
19833-12-6 |
C21H20O13 |
 |
Propanoic acid, 2,2-dimethyl-, 2-chloroethyl ester |
51479-37-9 |
C7H13ClO2 |
 |
Bumetanide Impurity 999 |
|
|
 |
Teneligliptin Impurity 16 |
|
|
 |
Tazobactam Impurity 9 |
|
|
 |
Favipiravir Impurities 1-19 |
|
|
![2-(4-ethylpiperazin-1-yl)-4-(4-methoxyphenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine](/CAS/20181212/GIF/CB510019552.gif) |
2-(4-ethylpiperazin-1-yl)-4-(4-methoxyphenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine |
|
C24H33N3O |
![(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(phenyl)Morpholine hydrochloride](/CAS/20150408/GIF/874460-46-5.gif) |
(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(phenyl)Morpholine hydrochloride |
874460-46-5 |
C20H20ClF6NO2 |
 |
(3R)-3α,5α,7β,9β,11α,13β-ヘキサメチル-4β,6β,7,12β-テトラヒドロキシ-14β-エチル-1-オキサシクロテトラデカン-2,10-ジオン |
3225-82-9 |
C21H38O7 |
 |
Rosuvastatin Impurity 155 |
|
|
 |
Alvimopan Impurity 1 |
2250243-53-7 |
C14H19NO |
 |
Cyanocobalamin Impurity F |
23208-66-4 |
C63H85CoN13O15P |
 |
E-テリフルノミド |
214782-56-6 |
C12H9F3N2O2 |
 |
Aripiprazole Impurity 11 |
|
|
 |
2′,3′-ジデオキシ-3′-チアシチジン |
134680-32-3 |
C8H11N3O3S |
![4-(benzyloxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid](/CAS/20180629/GIF/942195-83-7.gif) |
4-(benzyloxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid |
942195-83-7 |
C16H14N2O3 |
 |
Ticagrelor diastereoMer |
1459719-81-3 |
C9H9F2N |
 |
AOEGVETYSHPGBP-XYIDDFOTSA-N |
1887057-05-7 |
C41H55NO14 |
 |
Oxacillin Impurity H |
|
|
 |
Brepperazole impurity |
|
|
 |
Fulvestrant Impurity 12 |
|
|
![4-(8-クロロ-6,11-ジヒドロ-5H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-イル)-3-ピリジノール1-オキシド](/CAS/GIF/1193725-75-5.gif) |
4-(8-クロロ-6,11-ジヒドロ-5H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-イル)-3-ピリジノール1-オキシド |
1193725-75-5 |
C19H15ClN2O2 |
![シクロ[L-Abu-Sar-N-メチル-L-Leu-L-Val-N-メチル-L-Leu-L-Ala-D-Ala-N-メチル-L-Leu-N-メチル-L-Leu-N-メチル-L-Val-[(3R,4R)-3-ヒドロキシ*-N-メチル-5-[(E)-1-プロペニル]-L-Leu-]]](/CAS/GIF/59865-16-6.gif) |
シクロ[L-Abu-Sar-N-メチル-L-Leu-L-Val-N-メチル-L-Leu-L-Ala-D-Ala-N-メチル-L-Leu-N-メチル-L-Leu-N-メチル-L-Val-[(3R,4R)-3-ヒドロキシ*-N-メチル-5-[(E)-1-プロペニル]-L-Leu-]] |
59865-16-6 |
C62H111N11O12 |
 |
Eliglustat (1S,2S)-Isomer (Hemitartrate) |
1092472-70-2 |
C23H36N2O4 |
 |
7-(2-デオキシアデノシン-N6-イル)アリストラクタムI |
127191-86-0 |
C27H22N6O7 |
 |
Pralatrexate Impurity 11 |
|
|
 |
4,4'-イミノビスフェノール |
1752-24-5 |
C12H11NO2 |
![Cyclopropanecarboxylic acid, 1-[[(2-fluorophenyl)amino]carbonyl]-](/CAS/20200331/GIF/918642-61-2.gif) |
Cyclopropanecarboxylic acid, 1-[[(2-fluorophenyl)amino]carbonyl]- |
918642-61-2 |
C11H10FNO3 |
 |
lansoprazole Impurity 26 |
|
|
 |
Cabozantinib impurity 32 |
|
|
 |
4-クロロ-7-(2-クロロエトキシ)-6-(2-メトキシエトキシ)キナゾリン |
183322-20-5 |
C13H14Cl2N2O3 |
 |
Cefdinir CP Impurity I&J&K&L |
|
|
 |
Atorvastatin Impurity 45 (Sodium Salt) |
|
|
 |
Pitavastatin Impurity 58 |
|
|
 |
Entecavir Impurity 3 |
1391053-94-3 |
C12H15N5O4 |
 |
Ivabradine Impurity 21 HCl |
304465-03-0 |
C26H34N2O5 |
 |
Apixaban Amino Acid Impurity |
2206825-87-6 |
C25H27N5O5 |
 |
Fluvastatin EP Impurity C |
779995-42-5 |
C24H26FNO4 |
 |
Tenofovir Impurity 117 |
1643116-22-6 |
C8H11N5O |
 |
(-)-アポビンカミン酸エチル |
42971-12-0 |
C22H26N2O2 |
 |
Budesonide Impurity 29 |
|
|
 |
Trelagliptin Impurity 4 |
|
|
 |
7-PACE Impurity 1 |
|
|
 |
6,7-DiMethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one |
1177261-73-2 |
C19H24N4O5 |
 |
Clopidogrel Impurity 60 |
1430373-12-8 |
C25H26ClNO6S |
 |
RocuroniuM BroMide IMpurity 18 |
|
|
 |
(R,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
 |
(S)-4-Chloro-1,3-butanediol |
139013-68-6 |
C4H9ClO2 |
 |
(17α)-17-Hydroxy-3-oxo-19-norpregna-5(10),9(11)-diene-21-nitrile |
106111-42-6 |
C20H25NO2 |
 |
Pramipexole EP Impurity E |
106006-84-2 |
C10H15N3OS |
 |
Pitavastatin Impurity 75 |
|
|
![IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE)](/CAS/20180808/GIF/748812-53-5.gif) |
IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE) |
748812-53-5 |
C25H30N6O2 |
 |
Alpha-D-Methylglucoside |
|
|
 |
Granisetron Impurity F |
1364914-39-5 |
C18H24N4O |
![3-Azetidineacetic acid, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-](/CAS/20210111/GIF/2271228-52-3.gif) |
3-Azetidineacetic acid, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- |
2271228-52-3 |
C16H18N6O4S |
 |
3-Deschloro-4-Desfluoro-4-Chloro-3-Fluorogefitinib |
1603814-04-5 |
C22H24ClFN4O3 |
 |
Leak detection tracer standard gas |
|
|
 |
Aciclovir Impurity 7 |
|
|
 |
3,4-ジヒドロキシベンゼンアセトアルデヒド |
5707-55-1 |
C8H8O3 |
 |
Ampicillin Impurity C2 |
|
|
![5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-2-oxazolidinone](/CAS/20150408/GIF/1071765-44-0.gif) |
5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-2-oxazolidinone |
1071765-44-0 |
C14H19NO4 |
![Benzoic acid, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-, methyl ester](/CAS/20210305/GIF/1950587-19-5.gif) |
Benzoic acid, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-, methyl ester |
1950587-19-5 |
C21H14F4N4O3S |
 |
Peramivir Impurity 38 |
|
|